+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

South and Central America Genomics Market to 2027 - Regional Analysis and Forecasts By Technology; Application; End User and Country

  • ID: 4876871
  • Report
  • November 2019
  • 141 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The South and Central America genomics market is expected to reach US$ 1,263.61 Mn in 2027 from US$ 527.94 Mn in 2018. The market is estimated to grow with a CAGR of 10.4% from 2019-2027.

The growth of the genomics market is primarily attributed growth in technology developments in genomics rising investments & funds for genomics and development in the field of the agriculture and biotechnology. However, the market is likely to get impacted due to nonexistence of skilled professionals and high cost of equipment used in genomics are likely to pose a negative impact on the market growth. On the other hand, extensive use of genomics for medical applications is likely to have a positive impact on the growth of the South and Central America genomics market in the coming years.

Genomics is the field of science which deals in the production of whole genomes of organisms, and includes elements from genetics. Genomics uses a mixture of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. The large-scale Genome Centers will present the All of Us genomics platform. The genomics platform comprise achieving up to 200,000 genome-wide assays per year, generating high-quality genotyping and genome sequence data, and contributing to the advancement of technologies for population-scale genome analysis. Moreover, World Health Organization (WHO) to initiate almost US $1 million to launch the special program for research and Training in Tropical Diseases (TDR), which was the first broad genomic initiative involving Latin American countries. Thus, a good investments made by the government, companies is expected to increase the growth of the genomics market over the forecast years.

In 2018, the microarray segment held the largest market share in the genomics market, by technology. The microarray is expected to dominate its market share in 2027 owing to the microarrays have been widely used as single-nucleotide-polymorphism (SNP) genotyping platforms and the higher acceptance of the microarray in the field of genomics and wider applications. The next generation sequencing (NGS) segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

Research centers segment held the largest market share in the genomics market, by end user channel in 2018. This segment is also expected to dominate the market in 2027 owing research centers have developed various technologies in the field of the genomics and research centers provides researchers with references for further researches and this factor is likely to increase the market in the forecast period. Hospitals and clinics segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for genomic included in the report are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins., Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, QIAGEN, Eurofins Scientific.Novo Nordisk a/s and others.

Reasons to Buy
  • Save and reduce time carrying out entrylevel research by identifying the growth, size, leading players and segments in the South and Central America genomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South and Central America Genomics Market, thereby allowing players across the value chain to develop effective longterm strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize indepth South and Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decisionmaking process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Genomics Market - By Technology
1.3.2 Genomics Market - By Application
1.3.3 Genomics Market - By End User
1.3.4 Genomics Market - By Country

2. Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Genomics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert Opinions

5. Genomic Market - Key Industry Dynamics
5.1 Key Drivers
5.1.1 Growth in Investments & Funds for Genomics
5.1.2 Declining Cost of Sequencing Procedures
5.1.3 Technological Developments in Genomics
5.2 Key Restraints
5.2.1 Nonexistence of Skilled Professionals
5.2.2 High Cost of Equipment Used in Genomics
5.3 Key Opportunities
5.3.1 Scopes for the Consumer Genomics
5.3.2 Extensive Use of Genomics for Medical Applications
5.4 Future Trends
5.4.1 Technologies of Genomics
5.5 Impact Analysis

6. Genomics Market - Global Market Analysis
6.1 Global Genomics Market Revenue Forecasts And Analysis

7. Genomics Market -South and Central America Analysis
7.1 South and Central America Genomics Market Revenue Forecasts And Analysis

8. Genomics Market Analysis- By Technology
8.1 Overview
8.2 Genomics Market, By Technology 2018 & 2027 (%)
8.3 Next Generation Sequencing (NGS) Market
8.3.1 Overview
8.3.2 Next Generation Sequencing (NGS) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Sanger Sequencing Market
8.4.1 Overview
8.4.2 Sanger Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Microarray Market
8.5.1 Overview
8.5.2 Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Polymerase Chain Reaction (PCR) Market
8.6.1 Overview
8.6.2 Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Multiplex Ligation-dependent Probe Amplification (MLPA) Market
8.7.1 Overview
8.7.2 Multiplex Ligation-dependent Probe Amplification (MLPA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Other Technologies Market
8.8.1 Overview
8.8.2 Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Genomics Market Analysis- By Application
9.1 Overview
9.2 Genomics Market, By Application 2018 & 2027 (%)
9.3 Diagnostics Market
9.3.1 Overview
9.3.2 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Cardiogenetics Market
9.3.3.1 Overview
9.3.3.2 Cardiogenetics Market Revenue and Forecast to 2027 (US$ Mn)
9.3.4 Oncology Market
9.3.4.1 Overview
9.3.4.2 Oncology Market Revenue and Forecast to 2027 (US$ Mn)
9.3.4.3 Oncogenetics Market
9.3.4.3.1 Overview
9.3.4.3.2 Oncogenetics Market Revenue and Forecast to 2027 (US$ Mn)
9.3.4.4 OncoHemato Market
9.3.4.4.1 Overview
9.3.4.4.2 OncoHemato Market Revenue and Forecast to 2027 (US$ Mn)
9.3.5 Reproductive Disorders Market
9.3.5.1 Overview
9.3.5.2 Reproductive Disorders Market Revenue and Forecast to 2027 (US$ Mn)
9.3.6 Rare Diseases Market
9.3.6.1 Overview
9.3.6.2 Rare Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.3.7 Neurogenetics Market
9.3.7.1 Overview
9.3.7.2 Neurogenetics Market Revenue and Forecast to 2027 (US$ Mn)
9.3.8 Direct-to-Consumer Market
9.3.8.1 Overview
9.3.8.2 Direct-to-Consumer Market Revenue and Forecast to 2027 (US$ Mn)
9.3.9 Others Market
9.3.9.1 Overview
9.3.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Drug Discovery & Development Market
9.4.1 Overview
9.4.2 Drug Discovery & Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Precision/Personalized Medicine Market
9.5.1 Overview
9.5.2 Precision/Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Animal Research Market
9.6.1 Overview
9.6.2 Animal Research Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Agriculture Research Market
9.7.1 Overview
9.7.2 Agriculture Research Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others Market
9.8.1 Overview
9.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Genomics Market Analysis- By End User
10.1 Overview
10.2 Genomics Market, By End User 2018 & 2027 (%)
10.3 Research Centers Market
10.3.1 Overview
10.3.2 Research Centers Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Hospitals & Clinics Market
10.4.1 Overview
10.4.2 Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Pharmaceutical & Biotechnology Companies Market
10.5.1 Overview
10.5.2 Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Others Market
10.6.1 Overview
10.6.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

11. South And Central America Genomics Market Revenue And Forecasts To 2027
11.1.1 South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.3 South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.3.1 South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.3.1.1 South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.4 South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.5 South and Central America Genomics Market Revenue and Forecasts to 2027, By Country (%)
11.1.6 Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.1 Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.2 Brazil Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.6.3 Brazil Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.6.3.1 Brazil Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.6.3.1.1 Brazil Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.6.4 Brazil Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.7 Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 Argentina Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.7.3 Argentina Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.7.3.1 Argentina Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.7.3.1.1 Argentina Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.7.4 Argentina Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
11.1.8.3 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
11.1.8.3.1 Rest of South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
11.1.8.3.1.1 Rest of South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11.1.8.4 Rest of South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12. Genomics Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies done by the companies in the Market, 2018 (%)
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Product Launch
12.3.3 Approvals
12.3.4 Expansion
12.3.5 Product Expansion
12.3.6 Others
12.4 Inorganic Growth Strategies
12.4.1 Overview
12.4.2 Partnership
12.4.3 Acquisition
12.4.4 Collaboration
12.4.5 Agreement

13. Genomics Market-Key Company Profiles
13.1 F. Hoffmann-La Roche Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Information
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Beijing Genomics Institute
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mendelics Genomic Analysis SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Biosystems S.A.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Thermofisher Scientific Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 Swot Analysis
13.9.6 Key Developments
13.10 Eurofins Scientific
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product/ Services Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 THE IDENGENE
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Information
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Argentine Bioinformatics platform (BIA)
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 Swot Analysis
13.12.6 Key Developments
13.13 DLE
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Financial Overview
13.13.4 Product Portfolio
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 DASA
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Financial Overview
13.14.4 Product Portfolio
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Fleury Genômica
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Financial Overview
13.15.4 Product Portfolio
13.15.5 SWOT Analysis
13.15.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary Of Terms
Note: Product cover images may vary from those shown
3 of 3
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Eurofins
  • Qiagen
  • Agilent Technologies
  • BGI
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • QIAGEN
  • Eurofins Scientific.Novo Nordisk a/s
Note: Product cover images may vary from those shown
Adroll
adroll